Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants.

Feng, Sheng; Fan, Zechang; Zhou, Keyue; Ma, Shanshan; Liang, Mingzheng; Zhang, He; Xie, Yubiao; Ha, Zhuo; Jin, Ningyi; Lu, Huijun

Feng, Sheng; Fan, Zechang; Zhou, Keyue; Ma, Shanshan; Liang, Mingzheng; Zhang, He; Xie, Yubiao; Ha, Zhuo; Jin, Ningyi; Lu, Huijun.

Affiliation

Feng S; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Fan Z; College of Animal Science and Technology, Jilin Agricultural University, Changchun, China.
Zhou K; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Ma S; Beijing Northland Biotechnology Co., Ltd, Beijing, China.
Liang M; Beijing Northland Biotechnology Co., Ltd, Beijing, China.
Zhang H; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Xie Y; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Ha Z; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Jin N; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Lu H; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

J Med Virol ; 95(10): e29160, 2023 10.

Article de En | MEDLINE | ID: mdl-37822266

Sujet(s)
Mots clés

Delta; Omicron; cross-neutralization activity; protective efficacy; recombinant protein

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Animals Langue: En Journal: J Med Virol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google